Veteran private equity and operational leader focused on growth-stage technology and healthcare investments, Katherine Stoner leverages prior operating roles and board experience to source and scale portfolio companies. Known for driving commercial strategy, talent development and buy-and-build execution, she works across capital formation, M&A and governance with an emphasis on revenue expansion and margin improvement in software-enabled services.
Veteran private equity and operational leader focused on growth-stage technology and healthcare investments, Katherine Stoner leverages prior operating roles and board experience to source and scale portfolio companies. Known for driving commercial strategy, talent development and buy-and-build execution, she works across capital formation, M&A and governance with an emphasis on revenue expansion and margin improvement in software-enabled services.
Veteran operator-investor targeting growth-stage software-enabled healthcare and enterprise tech companies. Prioritizes revenue-centric value creation through go-to-market scaling, talent and leadership upgrades, and buy-and-build consolidation to expand margins and market share. Allocates capital into companies with validated product-market fit, recurring revenue and clear paths to unit-economics improvement, favoring active board governance and staged equity with performance-linked milestones. Time horizon is multi-year growth, risk-managed via operational intervention and disciplined follow-on reserve strategy.
Veteran operator-investor targeting growth-stage software-enabled healthcare and enterprise tech companies. Prioritizes revenue-centric value creation through go-to-market scaling, talent and leadership upgrades, and buy-and-build consolidation to expand margins and market share. Allocates capital into companies with validated product-market fit, recurring revenue and clear paths to unit-economics improvement, favoring active board governance and staged equity with performance-linked milestones. Time horizon is multi-year growth, risk-managed via operational intervention and disciplined follow-on reserve strategy.
| Trades 6482 | Longs Won 4587/6482 70% | Profit Factor 8.32 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $22.1M |
| Average Win $2.6M | Best Trade (Oct 16) $1.32B | Sharpe Ratio -11.9 |
| Average Loss -$756,825.1 | Worst Trade (Oct 15) -$88.74M | Z-Score 12.32 (100%) |
| Commissions $0 | Avg. Trade Length 1y 6m 6d | Expectancy $1.62M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 55,556 | 50,000 | 44,444 | 38,889 | 33,333 | 27,778 | 22,222 | 16,667 | 11,111 | 5,556 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 2.1M | $359.15M | $719.3M | - | $360.15M | 100.28% | +0.317% |
ABBV AbbVie Inc. | 507,376 | $84.42M | $144.53M | - | $60.11M | 71.2% | +0.515% |
ABT Abbott Laboratories | 934,540 | $96.55M | $97.77M | - | $1.22M | 1.26% | -0.062% |
ACN Accenture plc Class A | 4,561 | $1.24M | $1.02M | - | -$212,396.18 | -17.17% | -0.1% |
ACWI iShares MSCI ACWI ETF | 1,314 | $206,259 | $207,191.52 | - | $932.52 | 0.45% | -0.973% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 8,290 | $556,208.75 | $614,413.35 | - | $58,204.6 | 10.46% | -0.703% |
ADBE Adobe Inc. | 2,055 | $750,123.58 | $501,646.05 | - | -$248,477.53 | -33.12% | -3.004% |
ADI Analog Devices, Inc. | 629 | $249,820 | $254,002.78 | - | $4,182.78 | 1.67% | -0.032% |
ADM Archer-Daniels-Midland Co | 1.72M | $117.6M | $142.86M | - | $25.26M | 21.48% | +0.253% |
ADP Automatic Data Processing Inc. | 6,314 | $1.56M | $1.8M | - | $240,649.02 | 15.39% | +0.042% |
ADSK Autodesk, Inc. | 8,724 | $2.06M | $2.08M | - | $18,370.29 | 0.89% | -2.782% |
AEP American Electric Power Company, Inc. | 883,476 | $81.3M | $111.8M | - | $30.5M | 37.52% | +1.818% |
AES AES Corporation | 31,172 | $410,223.49 | $465,865.54 | - | $55,642.05 | 13.56% | -0.167% |
AFL Aflac Inc. | 3,234 | $267,735.08 | $384,183.03 | - | $116,447.95 | 43.49% | +0.631% |
AGG iShares Core U.S. Aggregate Bond ETF | 51,725 | $5.14M | $4.93M | - | -$212,065.46 | -4.12% | -0.089% |
AGX Argan Inc. | 514 | $279,950 | $181,354.61 | - | -$98,595.39 | -35.22% | -3.903% |
AJG Arthur J. Gallagher & Co. | 3,405 | $1.04M | $856,425.6 | - | -$182,697.31 | -17.58% | +0.568% |
AKRE Akre Focus ETF | 13,621 | $892,311.67 | $774,490.06 | - | -$117,821.61 | -13.2% | -1.37% |
ALB Albemarle Corporation | 607,037 | $63.21M | $58.23M | - | -$4.98M | -7.89% | -2.302% |
ALL Allstate Corporation | 2,343 | $530,916.78 | $568,177.5 | - | $37,260.72 | 7.02% | +1.21% |